An observational study in Keratoconus, sponsored by University Hospital, Bordeaux. Completed at 1 site in France. Open to participants aged 7 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-11-13.
Sponsored by University Hospital, Bordeaux · Observational
The principal objective of this study is to evaluate the frequency of KC inside family of patients with confirmed KC.
It's a familial, epidemiological, prospective, single-center study.
Keratoconus is a common bilateral progressive corneal ectatic disease causing visual impairment by inducing irregular astigmatism and corneal opacities. This disorder typically begins during teenage years, progresses until the age of 30 to 40 years and, in severe forms, may need a corneal transplantation.
Currently, keratoconus has not known etiopathogenesis, and it is difficult to detect subclinical forms.
Several risk factors seem to be implied, environmental and genetic : the risk of keratoconus in case of familial history of keratoconus isn't well known at that time, but seems to be important to consider to promote screening and follow up of patient with a familial history of keratoconus (KC).
307 studies on the registry are indexed under Keratoconus; 56 are open to participants now.
This study's enrollment of 95 is below the median of 130 across 94 observational studies indexed under Keratoconus.
Browse Keratoconus studies →University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.
Counted across the registry records on this site, refreshed daily.
100 patients + 2-5 members of family.
Case :
Family of case
Exclusion Criteria:
Galilee exam - Corn analysis with Optiwave Refractive Analysis
proportion of diagnosed keratoconus
Time frame: 1 day
Assesment of familial history on KC severity
Time frame: 1 day
Evaluation of KC severity
Time frame: 1 day
Plan to share: No
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Bordeaux